Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PHAR is expected to report earnings to fall 102.50% to 0 cents per share on March 12
Q4'25
Est.
$0.00
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.21
Q4'24
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of 10 cents, beating the estimate of 0 cents. With 15.75K shares outstanding, the current market capitalization sits at 1.12B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PHAR showed earnings on November 06, 2025. You can read more about the earnings report here.